These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 12501830

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge.
    Di Martino V, Ezenfis J, Benhamou Y, Bernard B, Opolon P, Bricaire F, Poynard T.
    AIDS; 1999 Jul 30; 13(11):1421-3. PubMed ID: 10449303
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
    Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, Tuberculosis Trials Consortium.
    Pharmacotherapy; 2007 Jun 30; 27(6):793-800. PubMed ID: 17542762
    [Abstract] [Full Text] [Related]

  • 25. Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications.
    Beukel van den Bout-van den CJ, Bosch ME, Burger DM, Koopmans PP, van der Ven AJ.
    AIDS; 2008 Jun 19; 22(10):1243-4. PubMed ID: 18525278
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lack of association between pregnancy and selected gastrointestinal adverse events among women prescribed nelfinavir.
    Reiss G, O'Brien M, Kopicko J, Clark RA.
    J Acquir Immune Defic Syndr; 2001 Apr 15; 26(5):513-4. PubMed ID: 11391176
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Caution regarding nelfinavir use in children and pregnant women.
    AIDS Clin Care; 2007 Nov 15; 19(11):96. PubMed ID: 18399001
    [Abstract] [Full Text] [Related]

  • 33. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN, Feinberg J, Goodrich J, Pilson RS, Siemon-Hryczyk P.
    Antivir Ther; 2003 Feb 15; 8(1):37-42. PubMed ID: 12713062
    [Abstract] [Full Text] [Related]

  • 34. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
    Bates DE, Herman RJ.
    Ann Pharmacother; 2006 Jun 15; 40(6):1190-5. PubMed ID: 16720703
    [Abstract] [Full Text] [Related]

  • 35. Nelfinavir in expanded postexposure prophylaxis causing acute hepatitis with cholestatic features: two case reports.
    Trapé M, Barnosky S.
    Infect Control Hosp Epidemiol; 2001 Jun 15; 22(6):333-4. PubMed ID: 11519908
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nelfinavir safe and effective in HIV/HCV patients.
    AIDS Patient Care STDS; 2003 Nov 15; 17(11):602-3. PubMed ID: 14750219
    [No Abstract] [Full Text] [Related]

  • 40. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
    Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Nájera R, Pumarola T, Alonso-Socas Mdel M, García-Bujalance S, Menéndez-Arias L, Spanish Group for the Study of Antiretroviral Drug Resistance.
    J Med Virol; 2007 Nov 15; 79(11):1617-28. PubMed ID: 17854027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.